Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery

Young Chul Yoo, Jae Kwang Shim, Jong Chan Kim, Youn Yi Jo, Jong Hoon Lee, Young Lan Kwak

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Background: The authors investigated the effect of a single preoperative bolus of erythropoietin on perioperative transfusion requirement and erythropoiesis in patients with preoperative anemia undergoing valvular heart surgery. Methods: In this prospective, single-site, single-blinded, randomized, and parallel-arm controlled trial, 74 patients with preoperative anemia were randomly allocated to either the erythropoietin or the control group. The erythropoietin group received 500 IU/kg erythropoietin and 200 mg iron sucrose intravenously 1 day before the surgery. The control group received an equivalent volume of normal saline. The primary endpoint was transfusion requirement assessed during the surgery and for 4 days postoperatively. Reticulocyte count and iron profiles were measured serially and compared preoperatively and on postoperative days 1, 2, 4, and 7. RESULTS:: Transfusion occurred in 32 patients (86%) of the control group versus 22 patients (59%) of the erythropoietin group (P = 0.009). The mean number of units of packed erythrocytes transfused per patient during the surgery and for 4 postoperative days (mean ± SD) was also significantly decreased in the erythropoietin group compared with the control group (3.3 ± 2.2 vs. 1.0 ± 1.1 units/patient, P = 0.001). The reticulocyte count was significantly greater in the erythropoietin group at postoperative days 4 (P = 0.001) and 7 (P = 0.001). Conclusions: A single intravenous administration of erythropoietin and an iron supplement 1 day before surgery significantly reduced the perioperative transfusion requirement in anemic patients undergoing valvular heart surgery, implicating its potential role as a blood conservation strategy.

Original languageEnglish
Pages (from-to)929-937
Number of pages9
JournalAnesthesiology
Volume115
Issue number5
DOIs
Publication statusPublished - 2011 Nov 1

Fingerprint

Erythropoietin
Thoracic Surgery
Injections
Ambulatory Surgical Procedures
Reticulocyte Count
Control Groups
saccharated ferric oxide
Anemia
Bloodless Medical and Surgical Procedures
Iron
Erythropoiesis
Intravenous Administration
Erythrocytes

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Yoo, Young Chul ; Shim, Jae Kwang ; Kim, Jong Chan ; Jo, Youn Yi ; Lee, Jong Hoon ; Kwak, Young Lan. / Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. In: Anesthesiology. 2011 ; Vol. 115, No. 5. pp. 929-937.
@article{2fcb51f4e8104cebb359803b4dd2bce2,
title = "Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery",
abstract = "Background: The authors investigated the effect of a single preoperative bolus of erythropoietin on perioperative transfusion requirement and erythropoiesis in patients with preoperative anemia undergoing valvular heart surgery. Methods: In this prospective, single-site, single-blinded, randomized, and parallel-arm controlled trial, 74 patients with preoperative anemia were randomly allocated to either the erythropoietin or the control group. The erythropoietin group received 500 IU/kg erythropoietin and 200 mg iron sucrose intravenously 1 day before the surgery. The control group received an equivalent volume of normal saline. The primary endpoint was transfusion requirement assessed during the surgery and for 4 days postoperatively. Reticulocyte count and iron profiles were measured serially and compared preoperatively and on postoperative days 1, 2, 4, and 7. RESULTS:: Transfusion occurred in 32 patients (86{\%}) of the control group versus 22 patients (59{\%}) of the erythropoietin group (P = 0.009). The mean number of units of packed erythrocytes transfused per patient during the surgery and for 4 postoperative days (mean ± SD) was also significantly decreased in the erythropoietin group compared with the control group (3.3 ± 2.2 vs. 1.0 ± 1.1 units/patient, P = 0.001). The reticulocyte count was significantly greater in the erythropoietin group at postoperative days 4 (P = 0.001) and 7 (P = 0.001). Conclusions: A single intravenous administration of erythropoietin and an iron supplement 1 day before surgery significantly reduced the perioperative transfusion requirement in anemic patients undergoing valvular heart surgery, implicating its potential role as a blood conservation strategy.",
author = "Yoo, {Young Chul} and Shim, {Jae Kwang} and Kim, {Jong Chan} and Jo, {Youn Yi} and Lee, {Jong Hoon} and Kwak, {Young Lan}",
year = "2011",
month = "11",
day = "1",
doi = "10.1097/ALN.0b013e318232004b",
language = "English",
volume = "115",
pages = "929--937",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. / Yoo, Young Chul; Shim, Jae Kwang; Kim, Jong Chan; Jo, Youn Yi; Lee, Jong Hoon; Kwak, Young Lan.

In: Anesthesiology, Vol. 115, No. 5, 01.11.2011, p. 929-937.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery

AU - Yoo, Young Chul

AU - Shim, Jae Kwang

AU - Kim, Jong Chan

AU - Jo, Youn Yi

AU - Lee, Jong Hoon

AU - Kwak, Young Lan

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Background: The authors investigated the effect of a single preoperative bolus of erythropoietin on perioperative transfusion requirement and erythropoiesis in patients with preoperative anemia undergoing valvular heart surgery. Methods: In this prospective, single-site, single-blinded, randomized, and parallel-arm controlled trial, 74 patients with preoperative anemia were randomly allocated to either the erythropoietin or the control group. The erythropoietin group received 500 IU/kg erythropoietin and 200 mg iron sucrose intravenously 1 day before the surgery. The control group received an equivalent volume of normal saline. The primary endpoint was transfusion requirement assessed during the surgery and for 4 days postoperatively. Reticulocyte count and iron profiles were measured serially and compared preoperatively and on postoperative days 1, 2, 4, and 7. RESULTS:: Transfusion occurred in 32 patients (86%) of the control group versus 22 patients (59%) of the erythropoietin group (P = 0.009). The mean number of units of packed erythrocytes transfused per patient during the surgery and for 4 postoperative days (mean ± SD) was also significantly decreased in the erythropoietin group compared with the control group (3.3 ± 2.2 vs. 1.0 ± 1.1 units/patient, P = 0.001). The reticulocyte count was significantly greater in the erythropoietin group at postoperative days 4 (P = 0.001) and 7 (P = 0.001). Conclusions: A single intravenous administration of erythropoietin and an iron supplement 1 day before surgery significantly reduced the perioperative transfusion requirement in anemic patients undergoing valvular heart surgery, implicating its potential role as a blood conservation strategy.

AB - Background: The authors investigated the effect of a single preoperative bolus of erythropoietin on perioperative transfusion requirement and erythropoiesis in patients with preoperative anemia undergoing valvular heart surgery. Methods: In this prospective, single-site, single-blinded, randomized, and parallel-arm controlled trial, 74 patients with preoperative anemia were randomly allocated to either the erythropoietin or the control group. The erythropoietin group received 500 IU/kg erythropoietin and 200 mg iron sucrose intravenously 1 day before the surgery. The control group received an equivalent volume of normal saline. The primary endpoint was transfusion requirement assessed during the surgery and for 4 days postoperatively. Reticulocyte count and iron profiles were measured serially and compared preoperatively and on postoperative days 1, 2, 4, and 7. RESULTS:: Transfusion occurred in 32 patients (86%) of the control group versus 22 patients (59%) of the erythropoietin group (P = 0.009). The mean number of units of packed erythrocytes transfused per patient during the surgery and for 4 postoperative days (mean ± SD) was also significantly decreased in the erythropoietin group compared with the control group (3.3 ± 2.2 vs. 1.0 ± 1.1 units/patient, P = 0.001). The reticulocyte count was significantly greater in the erythropoietin group at postoperative days 4 (P = 0.001) and 7 (P = 0.001). Conclusions: A single intravenous administration of erythropoietin and an iron supplement 1 day before surgery significantly reduced the perioperative transfusion requirement in anemic patients undergoing valvular heart surgery, implicating its potential role as a blood conservation strategy.

UR - http://www.scopus.com/inward/record.url?scp=80055016788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055016788&partnerID=8YFLogxK

U2 - 10.1097/ALN.0b013e318232004b

DO - 10.1097/ALN.0b013e318232004b

M3 - Article

C2 - 22027622

AN - SCOPUS:80055016788

VL - 115

SP - 929

EP - 937

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -